Skip to main content
. Author manuscript; available in PMC: 2014 Jul 14.
Published in final edited form as: Mol Cancer Res. 2014 Feb 26;12(5):784–794. doi: 10.1158/1541-7786.MCR-13-0638

Figure 4.

Figure 4

The expression of DDB2 protein, but not DDB2 mRNA, is reduced in ovarian CSCs. A to D, the protein level of DDB2 in various CSCs and their parental bulk cancer cells was determined using immunoblotting with anti-DDB2 antibody. The stem cell marker Nanog was also detected to show the CSC property. E to H, the mRNA level of DDB2 in various CSCs and their parental bulk cancer cells was determined using quantitative RT-PCR. The stem cell marker Nanog was also detected to show the CSC property. Bar, SD; n = 3; **, P < 0.01 compared with bulk cancer cells.